Georgia Bids > Bid Detail

Horse, turkey and guinea pig red blood cells

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Level of Government: Federal
Category:
  • 94 - Nonmetallic Crude Materials
Opps ID: NBD00159877412681520
Posted Date: Mar 15, 2023
Due Date: Mar 29, 2023
Solicitation No: 000HCVGD-2023-74075
Source: https://sam.gov/opp/79b9f9c35f...
Follow
Horse, turkey and guinea pig red blood cells
Active
Contract Opportunity
Notice ID
000HCVGD-2023-74075
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
CENTERS FOR DISEASE CONTROL AND PREVENTION
Office
CDC NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES
Looking for contract opportunity help?

Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.

General Information
  • Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Mar 15, 2023 06:26 am EDT
  • Original Date Offers Due: Mar 29, 2023 12:00 pm EDT
  • Inactive Policy: 15 days after date offers due
  • Original Inactive Date: Apr 13, 2023
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 9430 - MISCELLANEOUS CRUDE ANIMAL PRODUCTS, INEDIBLE
  • NAICS Code:
    • 325414 - Biological Product (except Diagnostic) Manufacturing
  • Place of Performance:
    Atlanta , GA 30329
    USA
Description

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to Lampire Biological Labs, Inc. for a period of 12 (twelve) months plus four (4) twelve (12)-month option years for turkey, guinea pig and horse red blood cells. This procurement will satisfy the Agency’s requirements because Lampire Biological Labs, Inc. has supplied red blood cells to CDC for five (five) years for use in the hemagglutination inhibition (HI) asssays for antigenic characterization of influenza viruses. A notable source of variation iin the HI assays stems from the source of red blood cells. In order to liimit this source of variability and maintain consistency in antigenic characterization of influenza strains, the Influenza Division must maintain the same source of red blood cells. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1 and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.



This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at tesslinger@cdc.gov by COB March 29, 2023.


Attachments/Links
No attachments or links have been added to this opportunity.
Contact Information
Contracting Office Address
  • 1600 CLIFTON ROAD
  • Atlanta , GA 30333
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Mar 15, 2023 06:26 am EDTCombined Synopsis/Solicitation (Original)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >